218 related articles for article (PubMed ID: 9456240)
1. A high-risk lesion for invasive breast cancer, ductal carcinoma in situ, exhibits frequent overexpression of retinoid X receptor.
Lawrence JA; Merino MJ; Simpson JF; Manrow RE; Page DL; Steeg PS
Cancer Epidemiol Biomarkers Prev; 1998 Jan; 7(1):29-35. PubMed ID: 9456240
[TBL] [Abstract][Full Text] [Related]
2. Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis.
Xu XC; Sneige N; Liu X; Nandagiri R; Lee JJ; Lukmanji F; Hortobagyi G; Lippman SM; Dhingra K; Lotan R
Cancer Res; 1997 Nov; 57(22):4992-6. PubMed ID: 9371489
[TBL] [Abstract][Full Text] [Related]
3. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
[TBL] [Abstract][Full Text] [Related]
4. Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer.
Widschwendter M; Berger J; Daxenbichler G; Müller-Holzner E; Widschwendter A; Mayr A; Marth C; Zeimet AG
Cancer Res; 1997 Oct; 57(19):4158-61. PubMed ID: 9331065
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid receptor and retinoid X receptor alterations in lung cancer precursor lesions.
Martinet N; Alla F; Farré G; Labib T; Drouot H; Vidili R; Picard E; Gaube MP; Le Faou D; Siat J; Borelly J; Vermylen P; Bazarbachi T; Vignaud JM; Martinet Y
Cancer Res; 2000 Jun; 60(11):2869-75. PubMed ID: 10850430
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid receptor and retinoid X receptor in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Sasano H
Jpn J Cancer Res; 2000 Nov; 91(11):1169-76. PubMed ID: 11092983
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
8. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH
Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828
[TBL] [Abstract][Full Text] [Related]
9. Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis.
Xu XC; Wong WY; Goldberg L; Baer SC; Wolf JE; Ramsdell WM; Alberts DS; Lippman SM; Lotan R
Cancer Res; 2001 Jun; 61(11):4306-10. PubMed ID: 11389049
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
[TBL] [Abstract][Full Text] [Related]
11. Ductal carcinoma in situ of the breast and heparanase-1 expression: a molecular explanation for more aggressive subtypes.
Maxhimer JB; Pesce CE; Stewart RA; Gattuso P; Prinz RA; Xu X
J Am Coll Surg; 2005 Mar; 200(3):328-35. PubMed ID: 15737842
[TBL] [Abstract][Full Text] [Related]
12. [Expression of the retinoic acid nuclear receptors and retinoid X receptor gene in human breast cancer].
Shao Z; Shen Z; Fontana JA
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):425-8. PubMed ID: 8697993
[TBL] [Abstract][Full Text] [Related]
13. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
[TBL] [Abstract][Full Text] [Related]
14. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas.
Nielsen BS; Rank F; López JM; Balbin M; Vizoso F; Lund LR; Danø K; López-Otín C
Cancer Res; 2001 Oct; 61(19):7091-100. PubMed ID: 11585740
[TBL] [Abstract][Full Text] [Related]
15. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
[TBL] [Abstract][Full Text] [Related]
16. Expression of nuclear retinoid receptors in normal, premalignant and malignant gastric tissues determined by in situ hybridization.
Jiang SY; Shen SR; Shyu RY; Yu JC; Harn HJ; Yeh MY; Lee MM; Chang YC
Br J Cancer; 1999 Apr; 80(1-2):206-14. PubMed ID: 10389997
[TBL] [Abstract][Full Text] [Related]
17. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
18. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.
O'Malley FP; Vnencak-Jones CL; Dupont WD; Parl F; Manning S; Page DL
Lab Invest; 1994 Jul; 71(1):67-72. PubMed ID: 8041120
[TBL] [Abstract][Full Text] [Related]
19. Expression of retinoid receptors in sebaceous cell carcinoma.
Chakravarti N; El-Naggar AK; Lotan R; Anderson J; Diwan AH; Saadati HG; Diba R; Prieto VG; Esmaeli B
J Cutan Pathol; 2006 Jan; 33(1):10-7. PubMed ID: 16441406
[TBL] [Abstract][Full Text] [Related]
20. Mouse skin tumor progression results in differential expression of retinoic acid and retinoid X receptors.
Darwiche N; Celli G; Tennenbaum T; Glick AB; Yuspa SH; De Luca LM
Cancer Res; 1995 Jul; 55(13):2774-82. PubMed ID: 7540949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
